BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3962017)

  • 1. Clinical reevaluation of the effect of oxybutynin chloride on uninhibited neurogenic and reflex neurogenic bladder.
    Kawabe K; Abe S; Kanda T; Tei K
    Urol Int; 1986; 41(1):16-20. PubMed ID: 3962017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
    J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical treatment with oxybutynin chloride in neurogenic incontinence].
    López Pereira P; Martínez MJ; Muguerza R; Jaureguizar E
    Cir Pediatr; 1993 Jan; 6(1):29-31. PubMed ID: 8499234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic bladder hyperactivity treated with Ditropan (oxybutynin chloride).
    Nagy F; Hamvas A; Frang D
    Int Urol Nephrol; 1990; 22(6):519-24. PubMed ID: 2093692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
    O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
    J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H; Nakamura R
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical oxybutynin chloride for relaxation of dysfunctional bladders.
    Brendler CB; Radebaugh LC; Mohler JL
    J Urol; 1989 Jun; 141(6):1350-2. PubMed ID: 2724432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P; Bussman G; Eksborg S
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency.
    Hashimoto K; Ohnishi N; Esa A; Sugiyama T; Park Y; Kurita T
    Urol Int; 1999; 62(1):12-6. PubMed ID: 10436424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment.
    Riva D; Casolati E
    Clin Exp Obstet Gynecol; 1984; 11(1-2):37-42. PubMed ID: 6370504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride.
    Moisey CU; Stephenson TP; Brendler CB
    Br J Urol; 1980 Dec; 52(6):472-5. PubMed ID: 7006730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
    Prasad KV; Vaidyanathan S
    Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
    Enzelsberger H; Kurz C; Helmer H
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.